Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Mar 19 | ANIK | Anika Therapeutics, Inc. | AGRANT◆ | 13,097 | — | — | — | Open the original filing on SEC.gov |
| Mar 15 | ANIK | Anika Therapeutics, Inc. | MEXER◆ | 2,658 | — | — | — | Open the original filing on SEC.gov |
| Mar 15 | ANIK | Anika Therapeutics, Inc. | FTAX | 781 | $14.20 | $11.1K | -3.1% | Open the original filing on SEC.gov |
| Mar 15 | ANIK | Anika Therapeutics, Inc. | MEXER | 2,658 | — | — | +12.0% | Open the original filing on SEC.gov |
| Mar 14 | ANIK | Anika Therapeutics, Inc. | MEXER◆ | 3,774 | — | — | — | Open the original filing on SEC.gov |
| Mar 14 | ANIK | Anika Therapeutics, Inc. | FTAX | 1,449 | $14.20 | $20.6K | -6.1% | Open the original filing on SEC.gov |
| Mar 14 | ANIK | Anika Therapeutics, Inc. | AGRANT | 1,161 | — | — | +5.2% | Open the original filing on SEC.gov |
| Mar 14 | ANIK | Anika Therapeutics, Inc. | MEXER | 3,774 | — | — | +20.1% | Open the original filing on SEC.gov |
| Mar 9 | ANIK | Anika Therapeutics, Inc. | MEXER◆ | 2,197 | — | — | — | Open the original filing on SEC.gov |
| Mar 9 | ANIK | Anika Therapeutics, Inc. | FTAX | 639 | $14.96 | $9.6K | -3.3% | Open the original filing on SEC.gov |
| Mar 9 | ANIK | Anika Therapeutics, Inc. | MEXER | 2,197 | — | — | +12.8% | Open the original filing on SEC.gov |